Efficacy and Safety of LBH589B in Adult Patients With Refractory Chronic Myeloid Leukemia in Accelerated or Blast Phase

NCT00449761 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

27

Enrollment

INDUSTRY

Sponsor class

Conditions

Leukemia, Myeloid, Chronic

Interventions

DRUG: LBH589

Sponsor

Novartis Pharmaceuticals